AI assistant
NANOVIRICIDES, INC. — Director's Dealing 2015
Jan 9, 2015
34915_dirs_2015-01-08_145e9ff2-41df-4e9a-916d-602c954b271e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2015-01-06
Reporting Person: BONIUK MILTON (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-04 | Common Stock, par value $0.001 | P | 25000 | $2.60 | Acquired | 1430391 | Direct |
Footnotes
F1: Includes 858,963 shares of Common Stock and warrants to purchase an additional 571,428 shares of Common Stock held by the Reporting Person and his wife. Does not include: 752,382 shares of Common Stock and warrants to purchase an additional 285,714 shares of Common Stock held by Boniuk Interests, Ltd.; 380,954 shares of Common Stock held by the Boniuk Charitable Foundation; or 952,381 shares of Common Stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible. Dr. Boniuk holds voting and dispositive power over the Boniuk Charitable Foundation, Boniuk Interests Ltd. and the Milton Boniuk IRA